Lilly's retatrutide delivers 30% weight loss in Phase 3 TRIUMPH-1 trial
All three dose levels, 4 mg, 9 mg and 12 mg, successfully met the primary and key secondary endpoints in 80 weeks
All three dose levels, 4 mg, 9 mg and 12 mg, successfully met the primary and key secondary endpoints in 80 weeks
By leveraging digital screening and remote consultation, the medical community is moving beyond the confines of the clinic
The therapy is suited for patients with severe valve leakage who face elevated surgical risk due to advanced age, frailty, or multiple medical complications
Deal includes exclusive option to acquire MiRus’ SIEGEL TAVR system for an additional $3 billion upon milestone achievements
A high-resolution CT scan with 0.5 mm slices was used to design a customised titanium implant tailored to the patient’s anatomy and bone loss pattern
The multi-target collaboration combines Regeneron’s industry-leading antibody capabilities with Parabilis’ novel Helicon peptide platform
Union Health Minister highlights India’s progress in universal health coverage, digital health, AI strategy and global vaccine cooperation during plenary session in Geneva
This positions its platform as a rapidly evolving engine for next-generation genetic medicine
Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics
Subscribe To Our Newsletter & Stay Updated